
The Myth of Genetic Superbabies
Gene-editing technologies are advancing rapidly, but human enhancement is harder than many seem to think
Jim Kozubek is the author of Modern Prometheus: Editing the Human Genome with Crispr-Cas9, published by Cambridge University Press. Credit: Nick Higgins
Gene-editing technologies are advancing rapidly, but human enhancement is harder than many seem to think
Science is messy, full of plot twists and competing interpretations—and the way we talk about it should reflect that truth
It could help large institutions reach new insights into disease—but also make it harder for small labs with original ideas to compete for grants
In psychology and psychiatry, it really means average or typical, but we too easily think of it as a synonym for how everyone is supposed to think and feel
Science doesn’t give us a script for what to value or believe in, but it helps us write that script
Unfortunately, the biggest recipients of government help are the pharmaceutical companies, not patients
A new report from the National Academies fails to include this crucial recommendation
Not now, certainly, but maybe someday—although there are plenty of hurdles to overcome first
Researchers are developing molecular switches that can inactivate transplanted genes, paving the way for safer gene therapies. First up—better treatments for cancer
Support science journalism.
Thanks for reading Scientific American. Knowledge awaits.
Already a subscriber? Sign in.
Thanks for reading Scientific American. Create your free account or Sign in to continue.
Create Account